EFFECT OF PARENTERAL LINOLEATE ON FATTY ACID COMPOSITION OF INFANT BRAIN AND LIVER

Total parenteral nutrition of newborn infants with Intralipid increased the 18:2 n-6 content and decreased the 22:6 n-3 levels of liver phosphatidylcholine and phosphatidylethanolamine.     

不同膳食脂肪酸对大鼠乳腺癌组织脂肪酸组成和脂代谢基因表达的影响

目的探讨不同膳食脂肪酸组成影响大鼠乳腺癌发生、发展的可能分子机制。方法用8种不同膳食脂肪酸组成(SFA、MUFA、n-6PUFA、n-3PUFA、1∶1n-6/n-3、5∶1n-6/n-3、10∶1n-6/n-3、1∶2∶1S/M/P其中n-6/n-31∶1)喂养SD雌性大鼠,并在大鼠乳腺癌模型的基础上,用气相色谱内标法观察大鼠乳腺组织脂肪酸组成改变,RT-PCR分析组织脂代谢调控基因(FAS、COX-2和5-LOX)的表达。结果在不同膳食脂肪酸构成中,只有1∶1n-6/n-3能有效抑制大鼠乳腺癌的发生。不同膳食脂肪酸构成可导致大鼠乳腺组织脂肪酸组成发生相应变化,且各组间的脂肪酸含量有显著差异。高乳腺癌诱发的SFA、MUFA、n-6PUFA、5∶1n-6/n-3、10∶1n-6/n-3和1∶2∶1S/M/P喂养组乳腺组织含有较多的C18∶1、C18∶2和C20∶4,而EPA和DHA含量极少。无或低乳腺癌诱发的n-3PUFA和1∶1n-6/n-3喂养组乳腺组织EPA和DHA明显增多,C20∶4含量显著减少。RT-PCR结果显示1∶1n-6/n-3低诱癌组较相应对喂组上调FAS、COX-2和5-LOXmRNA表达力度明显弱于其它高乳腺癌诱发组。结论不同膳食脂肪酸组成能明显改变大鼠乳腺组织脂肪酸组成,进而影响脂代谢基因FAS、COX-2和5-LOX表达,可能是大鼠乳腺癌发生的分子机制之一。     

Food use and health effects of soybean and sunflower oils.

This review provides a scientific assessment of current knowledge of health effects of soybean oil (SBO) and sunflower oil (SFO). SBO and SFO both contain high levels of polyunsaturated fatty acids (PUFA) (60.8 and 69%, respectively), with a PUFA:saturated fat ratio of 4.0 for SBO and 6.4 for SFO. SFO contains 69% C18:2n-6 and less than 0.1% C18:3n-3, while SBO contains 54% C18:2n-6 and 7.2% C18:3n-3. Thus, SFO and SBO each provide adequate amounts of C18:2n-6, but of the two, SBO provides C18:3n-3 with a C18:2n-6:C18:3n-3 ratio of 7.1. Epidemiological evidence has suggested an inverse relationship between the consumption of diets high in vegetable fat and blood pressure, although clinical findings have been inconclusive. Recent dietary guidelines suggest the desirability of decreasing consumption of total and saturated fat and cholesterol, an objective that can be achieved by substituting such oils as SFO and SBO for animal fats. Such changes have consistently resulted in decreased total and low-density-lipoprotein cholesterol, which is thought to be favorable with respect to decreasing risk of cardiovascular disease. Also, decreases in high-density-lipoprotein cholesterol have raised some concern. Use of vegetable oils such as SFO and SBO increases C18:2n-6, decreases C20:4n-6, and slightly elevated C20:5n-3 and C22:6n-3 in platelets, changes that slightly inhibit platelet generation of thromboxane and ex vivo aggregation. Whether chronic use of these oils will effectively block thrombosis at sites of vascular injury, inhibit pathologic platelet vascular interactions associated with atherosclerosis, or reduce the incidence of acute vascular occlusion in the coronary or cerebral circulation is uncertain. Linoleic acid is needed for normal immune response, and essential fatty acid (EFA) deficiency impairs B and T cell-mediated responses. SBO and SFO can provide adequate linoleic acid for maintenance of the immune response. Excess linoleic acid has supported tumor growth in animals, an effect not verified by data from diverse human studies of risk, incidence, or progression of cancers of the breast and colon. Areas yet to be investigated include the differential effects of n-6- and n-3-containing oil on tumor development in humans and whether shorter-chain n-3 PUFA of plant origin such as found in SBO will modulate these actions of linoleic acid, as has been shown for the longer-chain n-3 PUFA of marine oils.(ABSTRACT TRUNCATED AT 400 WORDS)     

孕妇葡萄糖耐量试验中血浆脂肪酸与血糖、胰岛素水平关系的研究

目的:研究血浆脂肪酸组成与孕妇糖耐量和餐后胰岛素水平的关系。方法:对76名怀孕24～28w的孕妇进行50g葡萄糖耐量试验,并收集血样测定血浆胰岛素、脂肪酸、甘油三酯和总胆固醇。血浆脂肪酸测定采用气相色谱法。结果:餐后血糖和胰岛素水平分别与血浆单不饱和脂肪酸、C14∶0、C16∶0、C16∶1n-7和C18∶1n-9的相关系数为正值(P<0.05),而与血浆多不饱和脂肪酸、C18∶2n-6、C20∶4n-6的相关系数为负值(P<0.05);另外餐后血糖水平与饱和脂肪酸的相关系数为正值(P<0.05),与C22∶6n-3的相关系数为负值(P<0.05)。进一步的多因素分析发现,控制年龄和孕前BMI后,血浆多不饱和脂肪酸含量分别与餐后血糖和胰岛素水平呈负相关;就单个脂肪酸而言,亚油酸(C18∶2n-6)和花生四烯酸(C20∶4n-6)与血糖水平呈负相关,亚油酸(C18∶2n-6)还与餐后胰岛素呈负相关。结论:本次研究以血浆脂肪酸组成作为膳食脂肪摄入水平的生物学指标,发现血浆中多不饱和脂肪酸比例较高,尤其是亚油酸和花生四烯酸比例较高对孕妇糖代谢起到有利作用。     

不同膳食脂肪酸构成影响MNU诱导大鼠乳腺肿瘤发生的研究

目的:探讨不同膳食脂肪酸对甲基亚硝基脲(MNU)诱导的大鼠乳腺肿瘤发生的影响。方法:用含15%脂肪(wt/wt)的半合成饲料喂养雌性SD大鼠。大鼠50d龄时,分8组喂养8种不同膳食脂肪酸组成的饲料,即SFA、MUFA、n-6PUFA、n-3PUFA、1∶1n-6/n-3、5∶1n-6/n-3、10∶1n-6/n-3和S/M/P为1∶2∶(1其中n-6/n-3为1∶1),每组又分肿瘤组和对喂组,肿瘤组,单次腹腔注射MNU(50mg/kgbw),相应的对喂组注射生理盐水,持续喂养18w。观察各组大鼠体重增长、乳腺肿瘤发生率、肿瘤多发率及肿瘤潜伏期等。结果:除喂养n-3PUFA的大鼠在实验6w后出现体重增长受阻外,其它组别的大鼠体重增长无明显差异。各对喂组大鼠均无乳腺肿瘤发生,而在MNU注射组中,喂养n-3PUFA的大鼠也无乳腺肿瘤发生,但喂养SFA、MUFA、n-6PUFA、5∶1n-6/n-3、10∶1n-6/n-3和S/M/P(1/2/1)大鼠乳腺肿瘤诱发率是1∶1n-6/n-3的2倍,且喂养1∶1n-6/n-3的大鼠,其肿瘤发生的潜伏期也最长。结论:不同膳食脂肪酸构成对MNU诱导的大鼠乳腺肿瘤发生影响不同。,1∶1n-6/n-3膳食脂肪酸构成能有效抑制MNU诱导的乳腺肿瘤发生。     

Perturbation of phospholipid and triacylglycerol fatty acid positional location in the heart of rats depleted of n-3 long-chain polyunsaturates

Rats depleted of long-chain polyunsaturated n-3 fatty acids (n-3–D) display several features of the metabolic syndrome, including obesity, liver steatosis, insulin resistance, hypertension, and cardiac hypertrophy. In this study, the heart phospholipid (PL) and triacylglycerol (TG) fatty acid content and pattern were compared between female control rats (C) and n-3–D rats. The sole n-3 fatty acids found in n-3–D rats, C22:5(n-3) and C22:6(n-3), were 10 to 20 times lower than in C. The total fatty acid content of PL was lower in n-3–D rats than C. No ectopic TG accumulation was found in n-3–D rats. In both PL and TG, the C16:0/C16:1(n-7) and C18:0/C18:1(n-9) ratios suggested increased Δ9-desaturase activity in n-3–D rats. The PL C18:2(n-6)/C20:4(n-6) and C20:4(n-6)/C22:4(n-6) ratios were also lower in n-3–D rats than C. Prior intravenous injection of a medium-chain TG:fish oil emulsion to n-3–D rats 60 to 120 minutes before killing augmented the PL content in C22:5(n-3) and C22:6(n-3), minimized the age-related decrease in the PL C18:1(n-9) relative content, and increased the TG C22:4(n-6) content. The alteration of cardiac function in n-3–D rats and its improvement after injection of medium-chain TG:fish oil emulsion coincides with parallel changes in heart lipid fatty acid content and pattern.     

广州成人膳食n-6/n-3脂肪酸比值与心血管疾病危险因素的关系

目的分析广州40～65岁居民膳食n-6/n-3脂肪酸比值与心血管疾病危险因素的关系。方法 40～65岁广州市民1133人,采用定量食物频数问卷调查对象的每日摄入食物种类和数量,计算能量和营养素摄入量,检测其红细胞膜脂肪酸构成、血脂及颈动脉内中膜厚度(IMT),分析n-6/n-3比值大小高Q3,中Q2,低Q1与血压、血脂和IMT的关系。结果 995人资料完整纳入分析。对象日均膳食总能量摄入为9.10±2.09MJ、脂肪供能比为(34.3±7.9)%。膳食n-6/n-3脂肪酸比值为(29.74±22.71):1,红细胞膜n-6/n-3脂肪酸比值为(2.7±1.0):1,膳食SFA:MUFA:PUFA为1:1.5:1。膳食n-3脂肪酸摄入量与红细胞膜n-3构成比、膳食n-6/n-3比值与红细胞膜n-6/n-3比值均呈显著正相关关系。膳食n-6/n-3比值最高组Q3(>31.16)对象的收缩压、TC和IMT水平显著高于最低组Q1(<17.40);红细胞膜n-6/n-3比值最高组Q3(>3.04)和中间组Q2(2.18～3.03)对象的收缩压、舒张压、TC、LDL-C及IMT水平均显著高于最低组Q1(≤2.17)。结论广州市40～65岁居民膳食n-6/n-3脂肪酸比值约为30:1;该比值小于17.40:1时,有较低的血压,总胆固醇及IMT水平。     

不同n-3/n-6多不饱和脂肪酸构成比膳食对大鼠一磷酸腺苷活化蛋白激酶表达的影响

目的研究不同n-3/n-6配比脂肪酸对大鼠磷酸腺苷酸活化蛋白激酶(AMP-activated protein kinase,AMPK)蛋白及活性表达的影响。方法58只SD大鼠适应性喂养7d后,尾静脉取血。根据血清总胆固醇水平随机分为:空白(基础饲料);高脂(高脂饲料);高脂1:1(高脂饲料+n-3/n-6=1:1配方油);高脂1:5(高脂饲料+n3/n6=1:5配方油);低脂1:1(脱脂基础饲料+n-3/n-6=1:1配方油);低脂1:5(脱脂基础饲料+n3/n6=1:5配方油)6组,喂养45d,观察大鼠摄食与体重增长。于实验前1d,15d,30d,45d分别各取血测血清总胆固醇水平,于D45处死动物。Western blotting分别分析肝和下丘脑组织中AMPK-α总蛋白及其活性表达。结果添加PUFA的4个比例组血清TC、体重与高脂组相比,显著降低,且低脂2个比例组和高脂1:1组均与高脂1:5组相比有显著差异。添加PUFA的4个比例组均与高脂组相比,大鼠下丘脑AMPK-α总蛋白表达水平明显降低,肝AMPK-α蛋白表达水平均比高脂组明显升高。结论PUFA改善血脂可能是通过增加肝AMPK表达,抑制下丘脑AMPK表达,增加肝脂肪酸氧化和抑制食欲,影响血脂代谢。     

膳食脂肪酸构成对小鼠淋巴细胞功能和脂质过氧化的影响

目的:探讨膳食多不饱和脂肪酸n-6/n-3比值对小鼠T淋巴细胞功能和脂质过氧化的影响。方法:96只BALb/c小鼠随机分为8组:饱和脂肪酸:单不饱和脂肪酸:多不饱和脂肪酸(S∶M∶P)为1:1.5:3.7和1:1.5:1,n-6/n-3比值分别为1、7.5、15、30,各4组。基础饲料采用AIN-93G配方,各组饲料的脂肪酸构成以食用油脂调配。饲养12w。测定小鼠T淋巴细胞功能,IL-2和血清丙二醛(MDA)水平。结果:S:M:P为1:1.5∶3.7,n-6/n-3为1时,小鼠T淋巴细胞增殖活性、IL-2水平均显著降低(P<0.05),且两者显著正相关(r=0.438,P<0.05),n-6/n-3为1、30时,血清MDA水平明显高于n-6/n-3为7.5和15组(P<0.05);S:M:P为1:1.5:1,n-6/n-3为1时,小鼠T淋巴细胞增殖活性、CD4+/CD8+T细胞比例、IL-2水平明显降低(P<0.05),n-6/n-3为1、30时,血清MDA水平明显高于n-6/n-3为7.5组(P<0.05)。结论:S:M:P为1:1.5:3.7和1:1.5:1,n-6/n-3为1时,T淋巴细胞功能受到抑制,其作用机制可能与IL-2有关;DHA对CD4+/CD8+T细胞比例的抑制作用可能大于ALA;结合脂质过氧化程度来考虑,膳食n-6/n-3为7.5～15范围内较为理想。     

Nutritional Importance of Selected Fresh Fishes,Shrimps and Mollusks to Meet Compliance with Nutritional Guidelines of n-3 LC-PUFA Intake in Spain

Fishery products are the main source of dietary n-3 long-chain polyunsaturated fatty acids (n-3 LC-PUFA). Following the European Commission’s request to address the risks and benefits of seafood consumption, and taking into account the great variability of nutrient and contaminant levels in fishery products, the present work aims to estimate the n-3 LC-PUFA provided per serving of selected fishes, shrimps and mollusks that are commonly consumed in Spain. This would enable the establishment of a risk–benefit analysis of fish consumption and provide recommendations for fish intake to comply with nutritional guidelines of n-3 LC-PUFA intake. We confirmed high variation in the pattern and contents of fatty acids for different species. n-6 PUFA were minor fatty acids, whereas palmitic (C16:0), oleic (C18:1 n-9), and mainly eicosapentaenoic (C20:5 n-3) and docosahexaenoic (C22:6 n-3) acids were the major fatty acids in the sample. Therefore, consumption of 2–3 servings per week of a variety of fishery products may contribute to compliance with the recommended daily n-3 LC-PUFA intake while maintaining an adequate balance to avoid contaminant-derived potential risks (metals and others). Taking the fatty acid content of fishery products described in this study into consideration, it is advisable to include one serving of fatty fish per week in order to meet recommended n-3 LC-PUFA levels.     

Lipid profiles of Chinese soft-shell turtle eggs (Pelodiscus sinensis)

Studies have shown potential beneficial functions of turtle eggs, but the mechanism is not clear. The species and content of lipids have a significant impact on human health. The major lipid classes and fatty acids composition of dried Chinese soft-shell turtle eggs were characterized with the aim of clarifying the potential beneficial functions of turtle eggs from the perspective of lipid nutrition. 100 g dried turtle eggs power contained an average of 24.7 g of triacylglycerol (TAG), 1.24 g of phospholipid (PL) and 0.72 g of cholesterol. The striking feature of the lipid composition was the abundant n-3 polyunsaturated fatty acids, resulting in an excellent n-6/n-3 ratio (1.27) and low atherogenic index (AI) and thrombogenic index (TI) values, which were considered to be a healthier option for the human diet. A total of 85 TAG molecular species and 95 PL molecular species were obtained by lipidomics. ΣcisC18:1, C18:2n-6 and C18:3n-3 were preferentially esterified at sn-2 position of TAG. Phosphatidylcholine (PC) and phosphatidylethanolamine (PE) accounted for more than 90 % of the PL, while no sphingomyelin (SM) was detected. C22:6n-3 and C20:5n-3 were preferentially bound to PE and lysophosphatidylcholine (LPC) respectively.     

Black soybean extract reduces fatty acid contents in subcutaneous,but not in visceral adipose triglyceride in high-fat fed rats

Abstract

It is known that black soybean (BS) extract, rich in polyphenols, has beneficial effects against obesity, inflammation and insulin resistance. However, detailed effects of BS on lipid metabolism have not been documented well. In the present study, we compared fatty acid composition in visceral and subcutaneous adipose tissues of high-fat fed (HFF) rats and BS administered HFF rats. Black soybean administration for 6 weeks influenced neither body nor adipose tissue weights, blood glucose, plasma insulin levels, or insulin sensitivity. However, BS reduced several saturated (C14:0 and C16:0), monounsaturated (C14:1n-5 and C18:1n-9) and n-6 polyunsaturated (C18:2n-6, C20:3n-6, C20:4n-6 and C22:4n-6) fatty acid contents in subcutaneous fat without any change in n-3 polyunsaturated fatty acid contents. No such effect was observed in fatty acid composition in visceral fat. Long-chain fatty acids are involved in regulation of inflammation. Therefore, those reduced fatty acids may be linked to the effects on suppressing inflammation.     

膳食n-6/n-3脂肪酸比值对小鼠淋巴细胞脂肪酸构成和功能的影响

目的观察膳食n6n3脂肪酸比值对淋巴细胞脂肪酸构成及细胞功能的影响。方法BALBc小鼠随机分为5组n6n3比值分别为1(A组)、75(B组)、15(C组)、30(D组)和正常对照组,其中实验组S∶M∶P模拟中国居民膳食脂肪酸摄入的S∶M∶P为1∶15∶1,正常对照组为AIN93G配方的1∶15∶37。基础饲料采用AIN93G配方,脂肪酸构成以食用油脂调配。饲养12周。测定小鼠T淋巴细胞功能,脾淋巴细胞脂肪酸构成、PGE2水平。结果n6n3比值接近1时,小鼠T淋巴细胞增殖活性、CD4+、CD8+T细胞比例、培养上清IL2、PGE2水平显著降低;淋巴细胞C18∶2、C20∶4、n6PUFA含量显著减少;C22∶6、C16∶1、C18∶1、总MUFA含量明显高于其他实验组。淋巴细胞C22∶6含量与淋巴细胞增殖活性显著负相关;C20∶5含量与CD4+T淋巴细胞比例、IL2水平显著负相关;C16∶1含量与CD4+、CD8+T淋巴细胞比例显著负相关。结论小鼠脾淋巴细胞的脂肪酸构成受膳食脂肪酸构成的影响;n6n3比值为1组与比值为30的膳食组相比较,小鼠T淋巴细胞增殖活性受到抑制。     

结构脂肪乳剂与物理混合的中/长链脂肪乳剂脂肪酸代谢比较研究

目的:比较结构脂肪乳剂(STG)与物理混合的中/长链脂肪乳剂(MCT/LCT)在人体内的脂肪酸代谢情况.方法:40例健康志愿者随机分为STG组和MCT/LCT组,每组20例.分别于早晨6h内匀速输注20%力文脂肪乳剂和20%力保肪宁脂肪乳剂1.0 g/(kg·次).并于给药前和给药后2、4、6和24 h留取血标本测定血...     

Effect of dietary blackcurrant seed oil on mouse macrophage subclasses of choline and ethanolamine glycerophospholipids

There have been reports that dietary gamma-linolenic acid [18:3(n-6)] and alpha-linolenic acid [18:3(n-3)] are capable of regulating cellular eicosanoid biosynthesis and inflammation. Because the eicosanoid cascade is regulated in part by the distribution of arachidonic acid [20:4(n-6)] among phospholipid subclasses, the effects of feeding blackcurrant seed oil [containing 18:3(n-6) and 18:3(n-3)] on the fatty acid composition of diacyl, alkylacyl and alkenylacyl subclasses of phosphatidylcholine (PC) and phosphatidylethanolamine (PE) were studied in mouse peritoneal macrophages. After 4 wk of dietary treatment, the relative distribution (mol %) of macrophage phospholipid classes and subclasses was not altered in animals fed blackcurrant seed oil relative to those fed corn oil [containing linoleic acid, 18:2(n-6)]. Macrophages from blackcurrant seed oil-fed animals had reduced levels of PC diacyl 18:3(n-6), 18:3(n-3), 20:3(n-6), 22:5(n-3), and alkylacyl 20:3(n-6), 22:5(n-3) and 22:6(n-3). In general, dietary blackcurrant treatment produced fatty acid alterations in PE subclasses that were similar to those in PC. A major exception, however, was the reduction in 20:4(n-6) levels in all PE subclasses, whereas no effect in PC subclass 20:4(n-6) levels was noted. These findings indicate i) that pronounced differences in the polyunsaturated fatty acid (PUFA) compositions of macrophage PC and PE subclasses exist following dietary fat manipulation and ii) that 18:3(n-6) and 18:3(n-3) feeding can increase potential anti-flammatory precursor levels of 20:3(n-6) and (n-3) PUFA in the macrophage.     

Low level of n-3 polyunsaturated fatty acids in erythrocytes is a risk factor for both acute ischemic and hemorrhagic stroke in Koreans

Evidence suggesting an association between n-3 polyunsaturated fatty acids (PUFA) and stroke risk has been inconsistent, possibly because previous studies have not differentiated between different stroke types. The present study investigated the hypothesis that tissue levels of n-3 PUFA are positively associated with hemorrhagic stroke and negatively associated with ischemic stroke. We recruited 120 subjects for this case-control study, with 40 cases each of hemorrhagic stroke, ischemic stroke, and unaffected controls. Patients with a family history of hemorrhagic stroke had a significantly increased risk for hemorrhagic stroke. Omega-3 Index (20:5n3 + 22:6n3 in erythrocytes) and 22:6n3 were negatively (P < .01) associated with the risk of both hemorrhagic and ischemic stroke in multivariate analyses. Saturated fatty acids 16:0 and 18:0 were positively associated, whereas 18:2n6 and 18:3n6 were negatively (P < .05) associated with risk of ischemic stroke. Monounsaturated fatty acid, 18:1n9, increased (P = .03) the odds of hemorrhagic stroke. Omega-3 Index and docosahexaenoic acid were significantly lower in patients with both subtypes of hemorrhagic stroke, subarachnoid and intracerebral hemorrhage, but only in one subtype of ischemic stroke, small-artery occlusion. Saturated fatty acids 16:0 and 18:0 were significantly higher, but 20:4n6 was significantly lower, in patients with small-artery occlusion. Linoleic acid was significantly lower in patients with small-artery occlusion and large-artery atherosclerosis, whereas 18:1n9 was higher in both subgroups of hemorrhagic stroke. In conclusion, the results of our case-control study suggest that erythrocyte n-3 PUFA may protect against hemorrhagic stroke and ischemic stroke, particularly in the case of small-artery occlusion.     

Alpha-linolenic acid and metabolism of cholesterol and long-chain fatty acids.

Animal studies have demonstrated that dietary 18:3n-3 reduces 20:4n-6 content in plasma and tissue lipids. At megadose levels of 18:3n-3, the reduction in phospholipid 20:4n-6 is brought about by a combination of inhibition of desaturase activities and redistribution of 20:4n-6 from phospholipids to neutral lipid pools. The shifting phenomenon is not apparent when the dietary level of 18:3n-3 is low. Dietary 18:3n-3 reduces cholesterol levels in blood and liver tissue; however, the mechanism by which this effect is mediated is not known. Further studies are warranted to investigate the role of dietary 18:3n-3 on cholesterol biosynthesis, storage, and mobilization into and from the tissues and on the secretion of cholesterol into bile. The effect of the ratio of dietary 18:2n-6 to SFA as a determinant of 20:4n-6 and lipid-lowering effects should be further explored in human subjects. It is important to elucidate whether dietary 18:3n-3 interacts with other nutrients to modulate the parameters implicated in the pathogenic processes. The optimum level of dietary 18:3n-3 required to obtain health beneficial effects needs to be determined. Specific effects of dietary 18:3n-3 on low- and high-density lipoprotein cholesterol levels also deserves further investigation before any recommendation to achieve health benefits can be made.     

Response of tissue phospholipid fatty acid composition to dietary (n-6) and replacement with marine (n-3) and saturated fatty acids in the rat

Nine groups of weanling male rats were maintained for ten weeks on a fat-free semi-synthetic diet supplemented with 10% by weight of oil, composed wholly of gamma-linolenic acid-rich evening primrose oil, or replaced partly or completely (25%, 50%, 75%, and 100%) by marine or hydrogenated coconut oils. Plasma phospholipid content and phospholipid fatty acid composition of plasma, red blood cells, liver, kidney, and heart were determined. Replacement of marine oil as 2.5% of the diet caused a decrease of plasma phospholipid concentration to 60%, with no furthur decrease at higher proportions. Except in the heart, marine oil in combination with evening primrose oil caused an increase in 20:3(n-6) concentration, and a decrease in 20:4(n-6) levels in all tissues examined. The ratio 20:3(n-6)/20:4(n-6) increased with increasing marine oil supplementation to the diet, but not when marine oil was the sole source of dietary fatty acids (10%). Replacement of hydrogenated coconut oil did not affect 20:3(n-6) concentrations. A decrease in 20:4(n-6) was observed when hydrogenated coconut oil was supplemented to the diet at 10%, causing a state of EFA deficiency as shown by the elevation of 20:3(n-9). There was an increase in 20:5(n-3) and 22:6(n-3) with increased marine oil intake. The ratio 20:3(n-6)/20:4(n-6) correlated significantly with 20:5(n-3), but not with 22:6(n-3), in all tissues except the heart, suggesting an inhibitory effect of 20:5(n-3) on delta-5-desaturase enzyme.     

Efficiency of conversion of alpha-linolenic acid to long chain n-3 fatty acids in man

Alpha-linolenic acid (18:3n-3) is the major n-3 (omega 3) fatty acid in the human diet. It is derived mainly from terrestrial plant consumption and it has long been thought that its major biochemical role is as the principal precursor for long chain polyunsaturated fatty acids, of which eicosapentaenoic (20:5n-3) and docosahexaenoic acid (22:6n-3) are the most prevalent. For infants, n-3 long chain polyunsaturated fatty acids are required for rapid growth of neural tissue in the perinatal period and a nutritional supply is particularly important for development of premature infants. For adults, n-3 long chain polyunsaturated fatty acid supplementation is implicated in improving a wide range of clinical pathologies involving cardiac, kidney, and neural tissues. Studies generally agree that whole body conversion of 18:3n-3 to 22:6n-3 is below 5% in humans, and depends on the concentration of n-6 fatty acids and long chain polyunsaturated fatty acids in the diet. Complete oxidation of dietary 18:3n-3 to CO2 accounts for about 25% of 18:3n-3 in the first 24 h, reaching 60% by 7 days. Much of the remaining 18:3n-3 serves as a source of acetate for synthesis of saturates and monounsaturates, with very little stored as 18:3n-3. In term and preterm infants, studies show wide variability in the plasma kinetics of 13C n-3 long chain polyunsaturated fatty acids after 13C-18:3n-3 dosing, suggesting wide variability among human infants in the development of biosynthetic capability to convert 18:3n-3 to 22:6n3. Tracer studies show that humans of all ages can perform the conversion of 18:3n-3 to 22:6n3. Further studies are required to establish quantitatively the partitioning of dietary 18:3n-3 among metabolic pathways and the influence of other dietary components and of physiological states on these processes.     

Effects of preterm infant formula supplementation with alpha-linolenic acid with a linoleate/alpha-linolenate ratio of 6: a multicentric study

OBJECTIVE: To investigate the effects of a milk formula supplemented with a alpha-linolenic acid (ALA) (18:2 n-6/18:3 n-3 ratio near 6/1) on plasma and red blood cell (RBC) fatty acids (FAs) in premature infants and compare with a non supplemented formula (18:2 n-6/18:3 n-3 = 22/1). DESIGN AND SUBJECTS: Infants of mothers who elected not to breast-feed were randomly assigned to either a high alpha linolenic formula (HLF: n = 31) group or a low alpha-linolenic formula (LLF: n = 32) control group. Infants fed human milk (HM: n = 25) were enrolled concurrently as a reference group. Anthropometric and biological measurements were made after two days (D2) and 15 d (D15) of enteral feeding and at the 37th week (W37) of postconceptual age. In HLF, the 18:3 n-3 content was 1.95% of total FAs (0.77% of total energy) and the 18:2 n-6/18:3 n-3 ratio was near 6/1. In LLF, the 18:3 n-3 content was 0.55% of total FAs (0.22% of total energy) and the 18:2 n-6/18:3 n-3 ratio was 22/1. RESULTS: ALA supplementation had minimal effect on the n-6 series, did not alter the anthropometric data and confirmed the conversion of ALA into docosahexaenoic acid (DHA). Throughout the study, it maintained, the RBC membrane DHA values within the confidence interval of those obtained in the HM group. Such was not the case with LLF CONCLUSION: alpha-linolenic acid supplementation (from Rapeseed oil and in a 18:2 n-6/18:3 n-3 ratio = 6) in premature infant formula can contribute efficiently to the maintenance of the n-3 status in the premature newborns.